Introducing a Pediatric Indication

Challenge: FLOVENT a widely used inhaled corticosteroid was not indicated for children because of safety concerns. With FDA approval of a pediatric indication, GSK wanted to soften the brand image of FLOVENT

Strategic Approach: Print ads were developed that depict the impact asthma can have on children and most importantly their childhood. KID FLOVENT helped ’soften’ the brand image